2023-11-02T08:30:06+00:00 2022-12-31 346565596 ERNST & YOUNG US LLP 2323 VICTORY AVENUE DALLAS TX 75219 990 2022-01-01 860098929 Vitalant VITA 4809464201 9305 E VIA DE VENTURA SCOTTSDALE AZ 85258 Maureen Musselman EVP, CFO 4809464201 2023-11-02 true MAUREEN MUSSELMAN 999009999 true Patrick Shields P01508556 2149698000 2022 2023-04-26 12:10:37Z X DAVID GREEN 9305 E VIA DE VENTURA SCOTTSDALE AZ 85258 718961993 false 6167 X WWW.VITALANT.ORG X 1943 AZ BLOOD BANKING AND RESEARCH. VITALANT EXISTS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. VITALANT, ONE OF THE NATION'S OLDEST AND LARGEST NONPROFIT COMMUNITY BLOOD SERVICE PROVIDERS, SUPPLIES COMPREHENSIVE TRANSFUSION MEDICINE SERVICES TO NEARLY 900 HOSPITALS AND HEALTH CARE PARTNERS FOR PATIENTS IN NEED ACROSS 40 STATES. 15 15 5462 437 0 0 16250573 7587096 660841189 623991770 141361429 39761984 18178235 28058422 836631426 699399272 1689490 1864493 0 363055941 374385465 0 0 315414075 312876270 680159506 689126228 156471920 10273044 765654359 810635110 202509567 235505675 563144792 575129435 VITALANT EXISTS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. VITALANT, ONE OF THE NATION'S OLDEST AND LARGEST NONPROFIT COMMUNITY BLOOD SERVICE PROVIDERS, SUPPLIES COMPREHENSIVE TRANSFUSION MEDICINE SERVICES TO NEARLY 900 HOSPITALS AND HEALTH CARE PARTNERS FOR PATIENTS IN NEED ACROSS 40 STATES. false false 507140617 1864493 562850053 BLOOD SERVICES DIVISION - BLOOD BANKING THE PRIMARY PURPOSE OF THE BLOOD SERVICES DIVISION (BSD) IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF BSD IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. BSD COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELL PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 40783083 54313868 VITALANT LABORATORIES (VL) VITALANT LABORATORIES' STAFF OF HIGHLY TRAINED AND EXPERIENCED PERSONNEL PROVIDE SUPPORT AND EXPERTISE TO HOSPITALS, TRANSFUSION AND TRANSPLANT CENTERS AND OTHER HEALTHCARE FACILITIES FOR THEIR TRANSFUSION MEDICINE NEEDS. VL OPERATES THREE LABORATORIES FOR (IRL) IMMUNOHEMATOLOGY REFERENCE LAB, (HLA) HISTOCOMPATIBILITY LABORATORY AND (CTL) CELLULAR THERAPY LABORATORY IN PHOENIX, WITH ADDITIONAL IRL'S IN SAN FRANCISCO, DENVER, CHICAGO AND PITTSBURGH. TOGETHER THEY SOLVE SOME OF THE MOST COMPLEX IMMUNOHEMATOLOGIC COMPATIBILITY CASES AND ENSURE LIFE-SAVING BLOOD AND CELLULAR THERAPY SERVICES TO HOSPITALS ALL ACROSS THE UNITED STATES. FOR HEALTHCARE FACILITIES IN CENTRAL ARIZONA, VL ALSO SERVES AS A BLOOD BANK, PROVIDING COMPLETE TRANSFUSION SERVICES INCLUDING PATIENT COMPATIBILITY TESTING AND DELIVERY. 35932065 32926243 VITALANT RESEARCH INSTITUTE (VRI) THE VITALANT RESEARCH INSTITUTE CARRIES OUT STUDIES FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHER AGENCIES) AND RECEIVES INTRAMURAL FUNDING FROM VITALANT BETWEEN $5.0M AND $6.0M EACH YEAR. VRI HAS HISTORICALLY BEEN NOTED FOR CONTRIBUTIONS TO INFECTIOUS DISEASE TESTING / MONITORING, EPIDEMIOLOGY / PUBLIC POLICY, AND SELECTED NON-INFECTIOUS RISKS OF TRANSFUSION. RECENT RESEARCH EFFORTS INCLUDE CHARACTERIZATION OF METABOLIC AND GENETIC FACTORS THAT INFLUENCE RED BLOOD CELL STABILITY, AND SINCE THE PANDEMIC, A HOST OF CRITICALLY IMPORTANT STUDIES TO UNDERSTAND SARS-COV-2 EPIDEMIOLOGY, THE SAFETY OF THE BLOOD SUPPLY, THE TIME COURSE OF ITS ANTIBODY RESPONSE/IMMUNITY AND THE EFFICACY OF COVID CONVALESCENT PLASMA. A PUBLIC SERVICE, VRI'S RESEARCH EXTENDS FAR BEYOND ORGANIZATIONAL DEVELOPMENT EFFORTS, BENEFITING PATIENTS ALL OVER THE US (AND THE WORLD) AS WELL AS COMPETING US BLOOD CENTERS, IMPROVING BLOOD PRODUCT QUALITY, RECIPIENT SAFETY, AND THE DONOR EXPERIENCE. VRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF RESEARCH SCIENTISTS IN A HOST OF TRANSFUSION MEDICINE SUBSPECIALTIES. VRI INVESTIGATORS PUBLISHED MORE THAN 100 PEER-REVIEWED ORIGINAL RESEARCH PAPERS IN 2022 ALONG WITH MANY MORE REVIEWS, EDITORIALS, BOOK CHAPTERS AND SCIENTIFIC MEETING ABSTRACTS. TOGETHER, VRI'S 12 INVESTIGATORS, 2 CLINICAL INVESTIGATORS, 16 AFFILIATED INVESTIGATORS, 7 CORE LEADERS, 10 ADMINISTRATIVE STAFF AND ~70 SCIENTISTS, TECHNOLOGISTS AND POST-DOCS HAVE CONTRIBUTED TO MAJOR DISCOVERIES IN TRANSFUSION SAFETY AND EFFICACY. 583855765 true true false false false false false false true true false true false true true false true false false true false false false false false false true false true false false false false false false false false true false false false true true true true false false true X 594 0 true 5462 true false true CJ false false false true true false false false false true false X 15 15 false false false false false false false true true false true true true true true true true true true true true true CA FL GA IL KS MI MS NJ NM PA RI SC TN WV X MAUREEN MUSSELMAN 4806755506 9305 E VIA DE VENTURA SCOTTSDALE AZ 85258 BILL GATES TRUSTEE/VICE CHAIR 3.0 0.0 X X 41000 0 0 JAMES T SCHRAITH TRUSTEE/CHAIR 4.0 1.0 X X 84516 0 0 PAUL E STANDER MD TRUSTEE/SECRETARY/TREASURER 3.0 0.0 X X 37375 0 0 CINDY ELKINS TRUSTEE (EFF 11/22) 2.0 0.0 X 0 0 0 CLIFFORD LOWELL MD PHD TRUSTEE 2.0 0.0 X 31500 0 0 HEATHER J ALLEN MD TRUSTEE 2.0 1.0 X 42000 0 0 JEFFREY SHUMWAY TRUSTEE (EFF 11/22) 2.0 0.0 X 0 0 0 JOHN S LEWIS TRUSTEE 2.0 2.0 X 48875 0 0 JONATHAN WATERS MD TRUSTEE 2.0 0.0 X 28750 0 0 KATHLEEN S PUSHOR TRUSTEE 2.0 0.0 X 41750 0 0 LINDA J BLESSING PHD TRUSTEE (THRU 04/22) 2.0 0.0 X 3500 0 0 PATRICIA ABREGO-SANTUCCI TRUSTEE 2.0 0.0 X 41375 0 0 ROBERT S COLE TRUSTEE 4.0 0.0 X 61625 0 0 RON W WAECKERLIN MD TRUSTEE 2.0 0.0 X 42750 0 0 SUNNY P CHICO TRUSTEE 2.0 1.0 X 44125 0 0 WILLIAM A DITTMAN MD TRUSTEE 2.0 0.0 X 42750 0 0 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 40.0 15.0 X 662580 0 69673 DAVID GREEN PRESIDENT/CEO 55.0 1.0 X 1427666 0 71665 MAUREEN MUSSELMAN EVP/CFO 40.0 15.0 X 598658 0 48376 ROBERT VAN TUYLE EVP, CHIEF OPERATIONS OFFICER 55.0 0.0 X 771733 0 72059 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 55.0 0.0 X 623655 0 71526 DIRK JOHNSON EVP/BLOOD OPERATIONS & CHIEF OF STAFF 55.0 0.0 X 514862 0 61388 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 55.0 0.0 X 616925 0 46695 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 55.0 0.0 X 532894 0 66419 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC OFFICER 55.0 0.0 X 701821 0 44959 BRIAN CUSTER SVP, RESEARCH & SCIENTIFIC PROGRAMS 45.0 0.0 X 487221 0 42941 CHARLES WILCOX III DIVISION VP, BLOOD SERVICES 45.0 0.0 X 503003 0 44557 CLIFFORD NUMARK SVP, CHIEF STRAT MKT DONOR SVC 45.0 0.0 X 527311 0 28313 KEVIN LAND VP, CLINICAL SERVICES 45.0 0.0 X 527752 0 66849 MICHAEL BUSCH MD SVP/RESEARCH & SCIENTIFIC PROG 45.0 0.0 X 627573 0 60890 9715545 0 796310 495 false true false CREATIVE TESTING SOLUTIONS 2424 W ERIE DRIVE TEMPE AZ 85282 LABORATORY TESTING 44099836 JONES LANG LASALLE AMERICAS INC 200 E RANDOLPH ST STE 430 CHICAGO IL 60601 FACILITIES MGMT SVCS 13695913 DOME CONSTRUCTION CORPORATION 393 EAST GRAND AVEMIE SOUTH SAN FRANCISCO CA 94080 CONSTRUCTION SVCS 7537211 UPS PO BOX 8948 LOS ANGELES CA 90189 DELIVERY SERVICES 5075763 TURNER CONSTRUCTION COMPANY 1401 ZUNI ST SUITE 301 DENVER CO 80204 CONSTRUCTION SVCS 4001058 180 3634976 3952120 744500 7587096 BLOOD & COMPONENT SRV FEE 541900 490751693 490751693 0 0 LABORATORY SERVICES 621500 74319034 74319034 0 0 PLASMA FOR FRACTIONATION 541900 34890983 34890983 0 0 RESEARCH CONTRACTS 541700 23605572 23605572 0 0 PHARMACEUTICAL PRODUCTS 446110 424488 424488 0 0 0 0 0 0 623991770 6753708 0 0 6753708 27642 0 0 27642 1932386 0 1932386 0 1932386 0 0 1932386 23156697 29414300 15469131 4093590 7687566 25320710 33008276 0 0 33008276 MISCELLANEOUS INCOME 900099 25726995 25726995 0 0 NON-OPERATING MISC INCOME 900099 371399 371399 0 0 0 0 0 0 26098394 699399272 650090164 0 41722012 1864493 1864493 7586679 0 7586679 0 293105486 253079686 40025800 0 13681665 10856723 2824942 0 38529634 34288103 4241531 0 21482001 18505741 2976260 0 888099 0 888099 0 401386 0 401386 0 321401 0 321401 0 10324043 5188035 5136008 0 6612135 1133151 5478984 0 46643774 37487549 9156225 0 19075295 9534065 9541230 0 44115193 38441292 5673901 0 14164052 13377974 786078 0 479864 0 479864 0 16214908 11194183 5020725 0 5884923 5341578 543345 0 OPERATING & TESTING SUPPLIES 132080862 130488382 1592480 0 PHARM/BLOOD PROD PURCHASE 5504981 5504981 0 0 RESEARCH COSTS 4754823 4754823 0 0 DONOR RECOGNITION & PROMO 2419452 1977539 441913 0 2991079 837467 2153612 0 689126228 583855765 105270463 0 84392677 71724969 291827 110576 129136767 105395447 0 0 0 0 416537 225251 18162854 19324190 9896251 10550791 424494991 233222613 165655323 191272378 324132166 281792701 500000 2808716 31770164 46104561 76164325 1299793 5161205 765654359 810635110 91164788 81171924 20715747 1026072 4051697 2758473 0 0 17246998 22579858 69330337 127969348 202509567 235505675 X 562870158 574975087 274634 154348 563144792 575129435 765654359 810635110 X 10273044 -40555460 42267059 X false true X true true true X 4934147 4705344 5980178 16250573 7587096 39457338 511696316 488055066 622696937 677106593 650090164 2949645076 0 0 0 516630463 492760410 628677115 693357166 657677260 2989102414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2989102414 4707735 21158309 18228814 5721323 8713736 58529917 0 4707735 21158309 18228814 5721323 8713736 58529917 0 0 0 0 0 0 0 521338198 513918719 646905929 699078489 666390996 3047632331 0.9808 0.9815 0.02 0.02 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 101634 15 101649 101351 283 101634 101365 -14 101351 28252227 5158659 33309521 101365 29958599 101426 -1807798 28252227 1.0 false false 20468032 20468032 139814215 73718168 66096047 55571804 20388940 35182864 151583579 86199212 65384367 57057361 52916293 4141068 191272378 INVESTMENT IN CREATIVE TESTING 45930970 INVESTMENT IN HEMEXCEL 100000 INVESTMENT IN IT SYNERGISTICS 73591 46104561 OPERATING LEASE LIABILITIES 85184786 PENSION EXPENSE - NOT FUNDED 32349621 DEFERRED PENSION - TEAMSTERS 5080907 LT TENANT IMPROVEMENT ALLOWANCE 4324883 CURRENT TENANT IMPROVEMENT ALLOW 692933 OTHER 336218 LONG TERM RENT STEP UP 127969348 X Schedule D, Part V, Line 4 Intended uses of endowment funds IRWIN MEMORIAL BLOOD CENTER, WHICH WAS MERGED INTO VITALANT, RECEIVED AN ENDOWMENT TO PROVIDE INFORMATION TO BLOOD-TRANSFUSED PATIENTS AND THEIR FAMILIES ON THE MEANS BY WHICH BLOOD UNITS ARE OBTAINED AND THE ESSENTIAL ROLE AND SACRIFICES OF BLOOD DONORS AND TO DEMONSTRATE APPRECIATION OF THE SACRIFICES OF BLOOD DONORS. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote AT DECEMBER 31, 2022, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ASC 740, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE SUBJECT TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2019, THROUGH THE CURRENT TAX YEAR, EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2018. AS OF DECEMBER 31, 2022, THE COMPANY HAS NOT IDENTIFIED ANY SIGNIFICANT UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2022. AS OF DECEMBER 31, 2022, THE COMPANY HAD NO INTEREST OR PENALTIES WHICH QUALIFIED FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. Central America and the Caribbean 0 0 Program Services CAPTIVE INSURANCE 2707079 0 0 0 0 0 0 2707079 0 2707079 true false true false false false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Accrual true UNIV OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 1500000 ESTABLISH HEMOSTASIS CLINIC BLOOD CENTER FDN OF THE INLAND NW 210 W CATALDO AVE SPOKANE WA 99201 464347438 501(C)(3) 155159 DONATION NAT BLOOD FDN RES & EDUC TRUST 4550 MONTGMRY STE 700 BETHESDA MD 20814 522059102 501(C)(3) 75000 NFB/CORD SUPPORT UNM FOUNDATION 700 LOMAS NE STE 108 ALBUQUQUE NM 87131 850275408 501(C)(3) 31103 FELLOWSHIP SUPPORT PROVIDENCE HEALTH CARE FDN E WASH 101 W 8TH AVE SPOKANE WA 99204 320014330 501(C)(3) 28059 GRANT FOR MLS TECH EQUIP FLIGHTS FOR LIFE PO BOX 26485 PHOENIX AR 85068 742453899 501(C)(3) 25000 DONATIONS PARALYZED VETERANS OF AMERICA 801 EIGHTEENTH ST NW WASHINGTON DC 20006 131946868 501(C)(3) 25000 2022 NVWG SPONSORSHIP HACKENSACK MERIDIAN HEALTH FDN 343 THORNALL ST 7TH FLOOR EDISON NJ 08837 300107825 501(C)(3) 8000 NETWORK WIDE SPONSORSHIP SIERRA SACRAMENTO VALLEY MED SOC 5380 ELVAS AVE 101 SACRAMENTO CA 95819 237003581 501(C)(3) 7495 DONATION 9 0 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. SPONSORSHIP AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES. X X X X false true false false false false false true false ROBERT VAN TUYLE EVP, CHIEF OPERATIONS OFFICER 502220 0 256603 0 12910 0 27000 0 45059 0 843792 0 0 0 DAVID GREEN PRESIDENT/CEO 820930 0 591365 0 15371 0 27000 0 44665 0 1499331 0 0 0 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 424738 0 226465 0 11377 0 20500 0 49173 0 732253 0 0 0 MAUREEN MUSSELMAN EVP/CFO 389732 0 196524 0 12402 0 27000 0 21376 0 647034 0 0 0 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 384216 0 204018 0 35421 0 27000 0 44526 0 695181 0 23004 0 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC OFFICER 454462 0 234644 0 12715 0 27000 0 17959 0 746780 0 0 0 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 396679 0 201480 0 18766 0 27000 0 19695 0 663620 0 0 0 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 337995 0 180326 0 14573 0 26936 0 39483 0 599313 0 2668 0 DIRK JOHNSON EVP/BLOOD OPERATIONS & CHIEF OF STAFF 319896 0 173411 0 21555 0 25924 0 35464 0 576250 0 7270 0 KEVIN LAND VP, CLINICAL SERVICES 370554 0 156318 0 880 0 26833 0 40016 0 594601 0 0 0 CHARLES WILCOX III DIVISION VP, BLOOD SERVICES 348983 0 132202 0 21818 0 24739 0 19818 0 547560 0 7769 0 CLIFFORD NUMARK SVP, CHIEF STRAT MKT DONOR SVC 372472 0 154655 0 184 0 15250 0 13063 0 555624 0 0 0 BRIAN CUSTER SVP, RESEARCH & SCIENTIFIC PROGRAMS 354552 0 132669 0 0 0 15250 0 27691 0 530162 0 0 0 MICHAEL BUSCH MD SVP/RESEARCH & SCIENTIFIC PROG 414596 0 187037 0 25940 0 27000 0 33890 0 688463 0 10829 0 Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan CERTAIN EMPLOYEES PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. THE FOLLOWING INDIVIDUALS EXPERIENCED A TAXABLE VESTING EVENT DURING THE YEAR AS FOLLOWS. THESE AMOUNTS WERE INCLUDED IN COLUMN (B)(III) AS TAXABLE WAGES. ANY PORTION OF THE DISTRIBUTION THAT WAS PREVIOUSLY REPORTED ON A PRIOR 990 AS DEFERRED HAS BEEN REPORTED IN COLUMN (F). ANTHONY BOBOS - $23,004 MICHAEL BUSCH, MD - $10,829 PETER MICHAELSON - $2,668 DIRK JOHNSON - $7,270 CHARLES WILCOX III - $7,769 Schedule J, Part I, Line 7 Non-fixed payments VITALANT HAS AN INCENTIVE PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN, FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. X BLOOD DONOR ITEMS 48 744500 Market value false true false Schedule M, Part I Explanations of reporting method for number of contributions Other - BLOOD DONOR ITEMS THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS IN COLUMN (B). Form 990, Part VI, Line 1a Delegate broad authority to a committee The Executive Committee has the powers of the Board of Trustees between Board meetings, unless prohibited by law, the Articles of Incorporation, the Amended and Restated Bylaws or the Board's policy. The Executive Committee is composed of the Chair, the Vice Chair, the immediate Past Chair (if re-elected and qualified), the Chairs of each regular committee, and any additional Trustees at-large selected by the Board of Trustees. Form 990, Part VI, Line 11b Review of form 990 by governing body THE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO APPROVE THE FILING OF THE TAX RETURNS. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE BOARD'S Audit, Quality, Compliance, & Risk Committee AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy EACH YEAR, THE BOARD OF TRUSTEES, OFFICERS AND KEY EMPLOYEES ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD'S AUDIT COMMITTEE AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, ALL INDIVIDUALS CONSIDERED TO BE 'DISQUALIFIED PERSONS' ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD'S AUDIT COMMITTEE AND DISCLOSED APPROPRIATELY ON THE FORM 990. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE BOARD OF TRUSTEES HAS A Compensation and Management Development Committee WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO, OFFICERS AND OTHER KEY EMPLOYEES OF THE CORPORATION. THIS PROCESS WAS COMPLETED IN 2020. THE MEMBERS OF THE Compensation and Management Development Committee OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE SESSION MINUTES OF THE BOARD MEETINGS. Form 990, Part VI, Line 19 Required documents available to the public UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTER. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. Form 990, Part VII, Section A, Line 1a, Column (D) Trustee Compensation Variability in Trustee compensation is attributed to hours spent on task forces, committees and service on affiliate Boards. Form 990, Part XI, Line 9 Other changes in net assets or fund balances PENSION GAIN - 21227953; GAIN ON DECONSOLIDATION OF LIFESTREAM - 1486777; Gain on acquisition of Foundation - 19552329; CANYON STATE PROPERTY HOLDING LLC 9305 E VIA DE VENTURA SCOTTSDALE AZ 85258 873307444 HOLDING COMPANY AZ 0 31652686 VITALANT PLASMASOURCE LLC 9305 E VIA DE VENTURA SCOTTSDALE AZ 85258 352770777 PLASMA COLLECTION AZ 0 0 VITALANT VITALANT FOUNDATION 875 GREENTREE RD PKWY CTR 5 PITTSBURGH PA 15220 251562715 FUNDRAISING PA 501(c)(3) 7 Vitalant true BLOOD CENTER FOUNDATION INLAND NORTHWEST 210 W CATALDO AVENUE SPOKANE WA 99201 464347438 FUNDRAISING WA 501(c)(3) Type III-FI NA false CANYON STATE INSURANCE COMPANY PO BOX 1085 113 S CHURCH ST GRAND CAYMAN CJ KY11102 981084327 CAPTIVE INSURANCE CJ VITALANT C Corporation 2026437 35552513 1 true true false true false false false true true false true false true true false true true false true true CANYON STATE INSURANCE COMPANY R 6847207 ACCRUAL HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA L 740505 ACCRUAL HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA J 469831 ACCRUAL VITALANT FOUNDATION C 3437127 ACCRUAL VITALANT FOUNDATION L 781089 ACCRUAL Schedule R, Part II THERE ARE VARIOUS RELATED TAX-EXEMPT BLOOD BANKING ORGANIZATIONS THAT ARE INCLUDED IN A GROUP EXEMPTION, AND THEREFORE, IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS ARE NOT REPORTED ON SCHEDULE R, PART II.